Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma

Published:2018-01-22 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Xu Guang-hua,Lou Ning,Shi Hang-chuan,Xu Yu-chen,Ruan Hai-long,Xiao Wen,Liu Lei,Li Xiang,Xiao Hai-bing,Qiu Bin,Bao Lin,Yuan Chang-fei,Zhou Ya-li,Hu Wen-jun,Chen Ke,Yang Hong-mei,Zhang Xiao-ping

Funder

National Natural Science Foundation of China

National High Technology Research and Development Program of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-017-3761-z.pdf

Reference56 articles.

1. Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev. 2008;34:193–205.

2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.

3. Leibovich BC, Lohse CM, Crispen PL, Boorjian SA, Thompson RH, Blute ML, Cheville JC. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol. 2010;183:1309–15.

4. Lam JS, Leppert JT, Belldegrun AS, Figlin RA. Novel approaches in the therapy of metastatic renal cell carcinoma. World J Urol. 2005;23:202–12.

5. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting NPC1 in Renal Cell Carcinoma;Cancers;2024-01-25

2. Metabolic alterations in hereditary and sporadic renal cell carcinoma;Nature Reviews Nephrology;2024-01-22

3. H19 recruited N6-methyladenosine (m6A) reader YTHDF1 to promote SCARB1 translation and facilitate angiogenesis in gastric cancer;Chinese Medical Journal;2023-06-05

4. Macrophage scavenger receptors: Tumor support and tumor inhibition;Frontiers in Oncology;2023-01-06

5. SR-BI expression regulates the gastric cancer tumor immune microenvironment and is associated with poor prognosis;BIOCELL;2023